Furthermore, in all MASLD patients complement 2 was repressed (Figure S12A,B), and except of C2, COLEC10 and C4BPB, the correlation between FGF21 and the expression of complement factors was strictly negative. This evidence concerns the gene C2 and metabolic dysfunction-associated steatotic liver disease.